Most (90%) FH patients have a mutation in the LDLr gene, whereas only a minority of patients have mutations in the apolipoprotein-B or PCSK9 genes that are associated with high cholesterol levels already in utero38. This evidence concerns the gene APOB and familial hyperaldosteronism.